CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC
14 Feb 2019
CHEIRON study: Docetaxel plus enzalutamide versus docetaxel as first-line chemotherapy for patients with mCRPC
Changes to the CME system in France
The importance of CME publishing
Can balanced CME truly be achieved without independence?
What is 'global collaboration' and why is it important?
Using the Outcomes Framework to improve patient care
CME as a change management engine
Accrediting learning in the workplace
The history and establishment of 'Continuing Medical Information'
How to better utilise the CME system
The European CME Forum meeting
The accreditation system for CME